Five services on the HNEV™ Regenerative RNA Platform — designed to be used alone or chained into one programme, with documentation at every gate.
Structured molecular profiling for research and translational programmes — deep insight into what RNA is doing and where.
Support for RNA biomarker development and vesicle-associated RNA analysis, designed for early detection research.
Controlled loading of RNA into plant- or MSC-derived vesicles, with proof that it arrived — and stayed — intact.
Plant- and MSC-derived vesicles (30–200 nm) produced to a defined concentration, scalable from research to regulated programmes.
The measurements that prove what a vesicle preparation is, and that it is safe to use.
A typical end-to-end programme moves left to right, with a documented output at every gate.
Objective, source, grade, timelines, confidentiality.
Vesicles at a defined concentration.
NTA, TEM/SEM, biomarkers, safety release.
RNA cargo loading and miRNA profiling.
Delivery, release, functional outcomes, report.
| Your question | Service | Typical output |
|---|---|---|
| Which miRNAs drive the effect we see? | RNA profiling | Differential expression, pathway evaluation |
| Can EV-associated RNA be a biomarker? | Diagnostic research | Biomarker validation, research-use panels |
| Can our RNA be delivered inside vesicles? | Cargo loading | Loading, encapsulation efficiency, release kinetics |
| We need vesicles at a defined concentration | Vesicle production | ≥ 1 × 10⁹ EVs/mL, research or GMP-aligned |
| Is this vesicle what we think — and safe? | Release testing | NTA, TEM/SEM, safety screen, COA, MSDS |
| Plant or MSC — which carries our signal? | RNA profiling | Side-by-side miRNA maps of plant and MSC vesicles |
Fixed scope, timeline and deliverables — ideal for a single profiling, loading or testing study.
Production, characterisation, loading and evaluation run as one documented programme.
We build with you toward a finished ingredient or product, with services feeding each stage.
Formulation and R&D teams in cosmetics and dermatology, regenerative-medicine researchers, diagnostics groups working with EV-associated RNA, and developers who need a partner to make and characterise vesicles to a defined specification.
Yes — a common chain is produce → characterise → load → evaluate delivery. Each stage is documented so it can stand alone or feed the next.
A written report with methods, data summaries and conclusions, plus COA and MSDS where material is supplied — designed to slot into your R&D or regulatory file.
Yes. Confidentiality agreements are standard; arrange one before sharing project details.
Services are research-stage: in vitro, analytical and production. For clinical development we can supply well-characterised vesicles to your programme’s specification.
Research question, bulk requirement or a product for your brand — we’ll route it to the right team and reply with a clear next step.
